Stay updated with breaking news from Thomas Ciulla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- VRDN-001 topline clinical results for THRIVE and THRIVE-2 on track for mid-2024 and year-end 2024 in patients with active and chronic thyroid eye disease , respectively - - Subcutaneous VRDN-003...
Cheryl Reppert doesn’t remember why she was awake at 1 a.m. on that August night when she received a final text message from her son, a soldier posted to Fort
/PRNewswire/ -- Treliant, an essential consulting partner to the global financial industry, has named Thomas Ciulla as a Managing Director in the firm's...
A retrospective study of nearly 19,000 eyes presented at ARVO 2023 found patients with GA lost 2 lines of vision at year 3 and are at meaningful risk of nAMD.
05.04.2023 - ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) - Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS), today announced the ... Seite 1